FDG PET for detection and therapy control of metastatic germ cell tumor

U Cremerius, PJ Effert, G Adam… - The Journal of Nuclear …, 1998 - search.proquest.com
tumors: enzymes of energy metabolism and related metabolites and cofactors. Page 1 22.
Komblith PL. Cummings C]. Smith BII, Brooks RA. Patronas NJ. Di Chiro G. Correlation of …

Imaging metastatic testicular germ cell tumours with18FDG positron emission tomography: prospects for detection and management

CB Wilson, HE Young, RJ Ott, MA Flower… - European journal of …, 1995 - Springer
The aim of this study was to investigate the role of positron emission tomography (PET) with
[18 F] fluoro-2-deoxyglucose (18 FDG) in metastatic testicular germ cell tumours. Twenty …

Fluorodeoxyglucose positron emission tomography in the initial staging of germ cell tumours

SF Hain, MJ O'Doherty, AR Timothy, MD Leslie… - European journal of …, 2000 - Springer
Testicular cancer is a rare tumour with the potential for cure at diagnosis. It is important,
however, to identify those patients with metastases at presentation so as to ensure that the …

Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET

JM Nuutinen, S Leskinen, I Elomaa, H Minn… - European Journal of …, 1997 - Elsevier
The aim of this study was to investigate whether 2-(F-18)-fluoro-2-deoxy-d-glucose-positron
emission tomography (FDG-PET) could reliably detect testicular cancer in patients following …

PET in the management of urologic malignancies

R Kumar, H Zhuang, A Alavi - Radiologic Clinics, 2004 - radiologic.theclinics.com
The ability of PET to study various biologic processes has opened up new possibilities in
both fundamental research and the day-to-day practice of medicine. At present, 2-deoxy-2 …

Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling

Y Sugawara, KR Zasadny, HB Grossman, IR Francis… - Radiology, 1999 - pubs.rsna.org
PURPOSE: To evaluate the feasibility of positron emission tomography (PET) with 2-[fluorine-
18]-fluoro-2-deoxy-d-glucose (FDG) in patients with germ cell tumor (GCT) to monitor …

Diagnostic Value of 18F-FDG Positron Emission Tomography for Detection and Treatment Control of Malignant Germ Cell Tumors

P Tsatalpas, B Beuthien-Baumann, J Kropp… - Urologia …, 2002 - karger.com
Introduction: The role of positron emission tomography (PET) with 2-[18F] fluoro-2-deoxy-D-
glucose ([18F] FDG) is currently under evaluation in urologic oncology. The aim of the …

Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?—Results of a study in 50 patients

U Cremerius, JE Wildberger, H Borchers, M Zimny… - Urology, 1999 - Elsevier
Objectives. To compare positron emission tomography (PET) using 18-fluoro-2-
deoxyglucose (FDG) with conventional clinical staging in unselected patients with germ cell …

Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single‐centre experience with …

CS Karapetis, AH Strickland, D Yip… - Internal medicine …, 2003 - Wiley Online Library
Aims: Fluorodeoxyglucose positron emission tomography (FDG‐PET) may detect residual or
recurrent malignancy in patients with germ cell tumours (GCT) following chemotherapy. The …

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse

SF Hain, MJ O'Doherty, AR Timothy, MD Leslie… - British journal of …, 2000 - nature.com
Differentiation of active disease from fibrosis/mature teratoma in patients with residual
masses or identifying of sites of recurrence in patients with raised markers following …